Geoffrey C Dunbar Insider Trading $CBIO CATALYST BIOSCIENCES, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Geoffrey C Dunbar.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Geoffrey C Dunbar. Geoffrey C Dunbar is SVP, Clin. Dev. & Reg. Affairs in CATALYST BIOSCIENCES, INC. ($CBIO) and VP Clin. Dev. & Reg. Affairs in CATALYST BIOSCIENCES, INC. ($CBIO) and VP, Clin. Dev. & Reg. Affairs in CATALYST BIOSCIENCES, INC. ($CBIO) and VP, Clin. Dev. & Reg. Affairs in CATALYST BIOSCIENCES, INC. ($CBIO).
Geoffrey C Dunbar in CATALYST BIOSCIENCES, INC.
Trading Symbol: CBIOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Geoffrey C Dunbar: SVP, Clin. Dev. & Reg. Affairs, VP, Clin. Dev. & Reg. Affairs, VP Clin. Dev. & Reg. Affairs, VP, Clin. Dev. & Reg. Affairs
Holdings: 1,153 shares
Current Value: $680
Latest Transaction: Mar 31 2011
$CBIO Market Capitalization: $6.51M
$CBIO Previous Close: $0.59
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Geoffrey C Dunbar in CATALYST BIOSCIENCES, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 31 2011 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | A | 26.05 | 55,500 | 1,445,775 | 55,500 | |
Dec 21 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 6,782 | 11,869 | 0 | |
Dec 21 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 2,100 | 3,675 | 0 | |
Dec 21 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 2,100 | 3,675 | 2,100 | |
Dec 21 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 26.02 | 8,882 | 231,120 | 1,153 | 10 K to 1.2 K (-88.51 %) |
Dec 21 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 8,882 | 15,544 | 10,035 | 1.2 K to 10 K (+770.34 %) |
Dec 21 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 26.08 | 2,100 | 54,765 | 1,153 | 3.3 K to 1.2 K (-64.56 %) |
Dec 21 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 2,100 | 3,675 | 3,253 | 1.2 K to 3.3 K (+182.13 %) |
Dec 20 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 200 | 350 | 4,200 | |
Dec 20 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 25.15 | 200 | 5,030 | 1,153 | 1.4 K to 1.2 K (-14.78 %) |
Dec 20 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 200 | 350 | 1,353 | 1.2 K to 1.4 K (+17.35 %) |
Dec 10 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 5.10 | 4,896 | 24,970 | 0 | |
Dec 10 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 5.10 | 6,354 | 32,405 | 0 | |
Dec 10 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 22.68 | 11,250 | 255,150 | 1,153 | 12.4 K to 1.2 K (-90.70 %) |
Dec 10 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 5.10 | 11,250 | 57,375 | 12,403 | 1.2 K to 12.4 K (+975.72 %) |
Nov 09 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 700 | 1,225 | 4,400 | |
Nov 09 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 25.02 | 700 | 17,512 | 1,153 | 1.9 K to 1.2 K (-37.78 %) |
Nov 09 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 700 | 1,225 | 1,853 | 1.2 K to 1.9 K (+60.71 %) |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 150 | 263 | 5,100 | |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 1,271 | 2,224 | 0 | |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 6,363 | 11,135 | 0 | |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 986 | 1,726 | 6,363 | |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 25.07 | 7,784 | 195,139 | 1,153 | 8.9 K to 1.2 K (-87.10 %) |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 7,784 | 13,622 | 8,937 | 1.2 K to 8.9 K (+675.11 %) |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 25.05 | 986 | 24,699 | 1,153 | 2.1 K to 1.2 K (-46.10 %) |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 986 | 1,726 | 2,139 | 1.2 K to 2.1 K (+85.52 %) |
May 17 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 1,494 | 2,615 | 7,349 | |
May 17 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 25.00 | 1,494 | 37,350 | 1,153 | 2.6 K to 1.2 K (-56.44 %) |
May 17 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 1,494 | 2,615 | 2,647 | 1.2 K to 2.6 K (+129.58 %) |
Apr 30 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 14,700 | 25,725 | 8,843 | |
Apr 30 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 24.00 | 14,700 | 352,800 | 1,153 | 15.9 K to 1.2 K (-92.73 %) |
Apr 30 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 14,700 | 25,725 | 15,853 | 1.2 K to 15.9 K (+1,274.93 %) |
Apr 28 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 200 | 350 | 23,543 | |
Apr 28 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 257 | 450 | 23,743 | |
Apr 28 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 24.00 | 200 | 4,800 | 1,153 | 1.4 K to 1.2 K (-14.78 %) |
Apr 28 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 200 | 350 | 1,353 | 1.2 K to 1.4 K (+17.35 %) |
Apr 28 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 24.00 | 257 | 6,168 | 1,153 | 1.4 K to 1.2 K (-18.23 %) |
Apr 28 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 257 | 450 | 1,410 | 1.2 K to 1.4 K (+22.29 %) |
Jan 21 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Option Exercise | A | 20.68 | 50,000 | 1,034,000 | 50,000 | |
Dec 18 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 21.86 | 22,602 | 494,170 | 1,153 | 23.8 K to 1.2 K (-95.15 %) |
Sep 17 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Option Exercise | M | 1.75 | 9,050 | 15,838 | 24,000 | |
Sep 17 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Option Exercise | M | 1.75 | 950 | 1,663 | 33,050 | |
Sep 17 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 16.27 | 9,050 | 147,226 | 23,755 | 32.8 K to 23.8 K (-27.59 %) |
Sep 17 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Buy | M | 1.75 | 9,050 | 15,838 | 32,805 | 23.8 K to 32.8 K (+38.10 %) |
Sep 17 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 16.01 | 950 | 15,214 | 23,755 | 24.7 K to 23.8 K (-3.85 %) |
Sep 17 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Buy | M | 1.75 | 950 | 1,663 | 24,705 | 23.8 K to 24.7 K (+4.00 %) |
Sep 18 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Option Exercise | M | 1.75 | 11,000 | 19,250 | 6,782 | |
Sep 18 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 17.19 | 11,000 | 189,101 | 23,755 | 34.8 K to 23.8 K (-31.65 %) |
Sep 18 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Buy | M | 1.75 | 11,000 | 19,250 | 34,755 | 23.8 K to 34.8 K (+46.31 %) |
Sep 09 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Option Exercise | M | 1.75 | 10,000 | 17,500 | 34,000 | |
Sep 09 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 15.02 | 10,000 | 150,191 | 23,755 | 33.8 K to 23.8 K (-29.63 %) |
Sep 09 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Buy | M | 1.75 | 10,000 | 17,500 | 33,755 | 23.8 K to 33.8 K (+42.10 %) |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Option Exercise | M | 1.75 | 7,900 | 13,825 | 44,000 | |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Option Exercise | M | 1.75 | 2,100 | 3,675 | 51,900 | |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 14.04 | 7,900 | 110,903 | 23,755 | 31.7 K to 23.8 K (-24.96 %) |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Buy | M | 1.75 | 7,900 | 13,825 | 31,655 | 23.8 K to 31.7 K (+33.26 %) |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 14.00 | 2,100 | 29,400 | 23,755 | 25.9 K to 23.8 K (-8.12 %) |
Aug 31 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Buy | M | 1.75 | 2,100 | 3,675 | 25,855 | 23.8 K to 25.9 K (+8.84 %) |
Jan 13 2009 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Option Exercise | A | 2.93 | 46,000 | 134,780 | 46,000 | |
Aug 19 2008 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 10.00 | 1,281 | 12,810 | 23,755 | 25 K to 23.8 K (-5.12 %) |
Aug 19 2008 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 10.00 | 700 | 7,000 | 25,036 | 25.7 K to 25 K (-2.72 %) |
Aug 19 2008 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 10.00 | 100 | 1,000 | 25,736 | 25.8 K to 25.7 K (-0.39 %) |
Aug 15 2008 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 10.00 | 1,473 | 14,730 | 25,836 | 27.3 K to 25.8 K (-5.39 %) |
Aug 15 2008 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 10.00 | 2,149 | 21,490 | 27,309 | 29.5 K to 27.3 K (-7.30 %) |
Jul 31 2008 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & Re ... | Sell | S | 9.02 | 5,000 | 45,108 | 29,458 | 34.5 K to 29.5 K (-14.51 %) |
Dec 21 2007 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & R ... | Option Exercise | A | 8.51 | 57,110 | 486,006 | 57,110 | |
Mar 07 2007 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP Clin. Dev. & Re ... | Option Exercise | M | 0.00 | 11,856 | 0 | 47,420 | |
Mar 07 2007 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP Clin. Dev. & Re ... | Buy | M | 1.75 | 11,856 | 20,748 | 34,458 | 22.6 K to 34.5 K (+52.46 %) |
Aug 18 2006 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | VP, Clin. Dev. & R ... | Option Exercise | A | 5.55 | 61,547 | 341,586 | 61,547 |
Page: 1